Mouth dissolving tablets II: An overview of evaluation techniques

Scientia Pharmaceutica

Volumn 77, Issue 2, 2009, Pages 327-341

  Shukla, Dali ^a   Chakraborty, Subhashis ^a   Singh, Sanjay ^a   Mishra, Brahmeshwar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Disintegration test; E tongue; Evaluation technique; Mouth dissolving; Taste masking

Indexed keywords

EXCIPIENT;

BLISTER PACK; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; FREEZE DRYING; MASKING; MOISTURE; MOUTH DISSOLVING TABLET; PATIENT COMPLIANCE; POROSITY; PROCESS TECHNOLOGY; REVIEW; TABLET FORMULATION; TASTE; TENSILE STRENGTH; TIME; WATER ABSORPTION; WETTABILITY;

EID: 67149099804     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0811-09-02     Document Type: Review

References (35)

1. Lindgren S, Janzon L. Prevalence of swallowing complaints and clinical findings among 50-79-year-old men and women in an urban population. Dysphagia.1991; 6: 187-192. doi:10.1007/BF02493524
2. Hanawa T. New oral dosage form for elderly patients: preparation and characterization of silk fibroin gel. Chem Pharm Bull. 1995; 43: 284-288. PMid:7728934
3. Gisel EG. Oral motor skills following sensorimotor intervention the moderately eating impaired child with cerebral palsy. Dysphagia.1994; 9: 180-192. doi:10.1007/BF00341263 (Pubitemid 24218301)
4. Virely P, Yarwood R. Zydis - a novel, fast dissolving dosage form. Manuf Chem. 1990; 61: 36-37.
5. Pebley WS, Jager NE, Thompson SJ. Rapidly disintegrating tablet. US Patent 5, 298, 261. 1994 March 29.
6. Watanabe Y. New compressed tablet rapidly disintegrating in the mouth using crystalline cellulose and a disintegrant. Biol Pharm Bull. 1995; 18: 1308-1310. PMid:8845832
7. Myers GL, Battist GE, Fuisz RC. Process and apparatus for making rapidly dissolving dosage units and product there from. PCT Patent WO 95/34293-A1.1995 Dec 21.
8. Allen LV, Wang B. Process for making a particulate support matrix for making a rapidly dissolving tablet. US Patent 5,587,180. 1996 Dec 24.
9. Koizumi KI, Watanabe Y, Morita K, Utoguchi N, Matsumoto M. New method for preparing high porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int J Pharm. 1997; 152: 127-131. doi:10.1016/S0378-5173(97)04924-4927 (Pubitemid 27254969)
10. Bhaskaran S, Narmada GV. Rapid dissolving tablet a novel dosage form. Indian Pharmacist. 2002; 1: 9-12.
11. Elan Corporation, plc. Orally disintegrating tablets (ODT) - Nanomelt™ http://www.elan.com/EDT/nanocrystal%5Ftechnology/orally- disintegrating-tablet.asp.
12. Bess WS, Kulkarni N, Ambike SH, Ramsay MP. Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1. US Patent 7067116. 2006 Jun 27.
13. Tablets. European Pharmacopoeia. Ed. 4, Supplement 4.2; 2002. p2435.
14. Bi YX, Sunada H, Yonezawa Y, Danjo K. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm. 1999; 25: 571-581. doi:10.1081/DDC-100102211 (Pubitemid 29186288)
15. Liang AC, Chen LH. Fast-dissolving intraoral drug delivery systems. Expert Opin Ther Pat. 2001; 11:981-986 doi:10.1517/13543776.11.6.981 (Pubitemid 32536833)
16. Harmon TM. Eurand: Orally disintegrating tablets: A valuable life cycle management strategy. http://www.eurand.com/upload/WhitePapers/ Pharmaceutial%20Commerce%20-%20FINAL.pdf
17. Bandari S, Mittapalli RK, Gannu R, Rao YM. Orodispersible tablets: An overview. Asian J Pharm. 2008; 2: 2-11. doi:10.4103/0973-8398.41557
18. Allen T. In: Particle size measurement, 5th ed. London: Chapmanand Hall,1997:149-187.
19. Alvarez-Lorenzo C, Gómez-Amoza JL, Martínez-Pacheco R, Souto C, Concheiro A. Evaluation of low-substituted hydroxypropylcelluloses (L-HPCs) as filler-binders for direct compression Int J Pharm. 2000; 197:107-116 doi:10.1016/S0378-5173(99)00456-461
20. Sunada H, Bi Y. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technology. 2002; 122: 188-198. doi:10.1016/S0032-5910(01)00415-416
21. Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull. 1996; 44: 2121-2127. PMid:8945778 (Pubitemid 26396765)
22. Narazaki R, Harada T, Takami N, Kato Y, Ohwaki T. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull. 2004, 52: 704-707. PMid:15187391 (Pubitemid 41685508)
23. Motohiro O, Hayakawa E, Ito K, Tokuno M, Morimoto K, Watanabe K. US Patent Application 20010014340. 2001 Aug 16.
24. Morita Y, Tsushima Y, Yasui M, Termoz R, Ajioka J, Takayama K. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera. Chem Pharm Bull. 2002; 50: 1181-1186. doi:10.1248/cpb.50.1181 (Pubitemid 41656829)
25. Fu Y, Jeong SH, Park K. Preparation of fast dissolving tablets based on mannose. ACS Symp Ser. 2006; 924: 340-351.
26. Harada T, Narazaki R, Nagira S, Ohwaki T, Aoki S, Iwamoto K. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test. Chem Pharm Bull. 2006; 54: 1072-1075. doi:10.1248/cpb.54.1072 (Pubitemid 44166393)
27. El-Arini SK, Clas SD. Evaluation of disintegration testing of different fast dissolving tablets using the texture analyzer. Pharm Dev Technol. 2002; 7: 361-371. doi:10.1081/PDT-120005732 (Pubitemid 34983127)
28. Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier JP, Piccerelle PH. Determination of the in-vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm. 2005; 292: 29-41. doi:10.1016/j.ijpharm.2004.08.019 (Pubitemid 40255786)
29. Bose Corporation. Evaluation of orally disintegratingtablets (ODTs) using precision compressive loading. http://www.bose-electroforce.com/pdf/Appbrief- ODTs.pdf.
30. Klancke J. Dissolution testing of orally disintegrating tablets. Dissolution Technol. 2003; 10(2): 6-8.
31. Siewert M, Dressman J, Brown C, Shah V. FIP/AAPS Guidelines for dissolution/in-vitro release testing of novel/special dosage forms. AAPS PharmaSciTech, 2003; 4: article 7. doi:10.1208/pt040107 (Pubitemid 36313473)
32. Agarwal R, Mittal R, Singh A. Studies of ion-exchange resin complex of chloroquine phosphate. Drug Dev Ind Pharm. 2000; 26: 773-776. doi:10.1081/DDC-100101297 (Pubitemid 30397333)
33. Shukla D, Chakraborty S, Singh S, Mishra B. Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets. Chem Pharm Bull. 2009; 57: 337-345. doi:10.1248/cpb.57.337
34. Gole D, Savall T, Lyou-fu G, Dale W, Paul K, Davies JD. Taste-masked resinate and preparation thereof. US Patent Application 20050036977. 2005 Feb 17.
35. Murray OJ, Dang W, Bergstrom D. Using an electronic tongue to optimize taste-masking in a lyophilized orally disintegrating tablet formulation. Pharm Technol. 2004; 28: 42-52. (Pubitemid 39079857)